Posted on Leave a comment

Up-scaling the differentiation of functional cardiomyocytes.

A key area of research for the EBiSC team is focusing on robust iPSC cardiac differentiation, generating cardiomyocytes from both healthy donors and patients with cardiac disease. Alongside optimising protocols for differentiation, upscaling and cryopreservation, we offer characterisation and functional phenotyping services to support disease modelling and drug discovery.

By combining high-quality iPSC resources with expert differentiation and analysis, EBiSC helps researchers build reliable, human-relevant cardiac models.

Get in touch via Contact@EBiSC.org to discuss your needs.

Posted on Leave a comment

EBiSC expands access in Japan through partnership with KAC!

We’re pleased to announce that KAC Co., Ltd. is now the official partner supporting the promotion and delivery of EBiSC iPSC lines in Japan.
KAC brings extensive experience supplying cell lines, primary cells, culture media, sera and research reagents to laboratories across Japan. Through this collaboration, researchers will benefit from simplified local access, improved logistics and dedicated support when ordering from the EBiSC catalogue of 1000 high-quality iPSC lines covering more than 45 disease areas.

This partnership strengthens EBiSC’s global network and supports our mission to make well-characterised iPSC resources accessible to researchers worldwide.

🧬 Explore EBiSC’s iPSC collection: www.ebisc.org
📩 Contact KAC: https://lnkd.in/eXZi8XP8
🌐 www.kacnet.co.jp